{"id":23149,"date":"2023-09-07T13:07:17","date_gmt":"2023-09-07T17:07:17","guid":{"rendered":"https:\/\/platohealth.ai\/importer-of-record-for-clinical-trials-imperial-clinical-research-services-blog\/"},"modified":"2023-09-07T15:17:43","modified_gmt":"2023-09-07T19:17:43","slug":"importer-of-record-for-clinical-trials-imperial-clinical-research-services-blog","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/importer-of-record-for-clinical-trials-imperial-clinical-research-services-blog\/","title":{"rendered":"Importer of Record for Clinical Trials – Imperial Clinical Research Services Blog","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"

Avoiding<\/b> <\/b>\u201cCustoms<\/b> <\/b>Chaos\u201d in Clinical Trials<\/b> <\/b>Means<\/b> <\/b>Working<\/b> <\/b>Closely<\/b> <\/b>with<\/b> <\/b>Your<\/b> <\/b>Importer<\/b> <\/b>of<\/b> Record<\/b><\/span><\/h3>\n

Many global clinical trial shipments get muddled regarding the critical role and responsibilities of the importer of record<\/span><\/a> (IOR) for clinical trials. The IOR is the person or entity responsible for ensuring that the goods brought into the country are imported in adherence to the laws and regulations of the importing country.<\/span><\/p>\n

To prevent delays in your clinical study shipments, proactive planning and selection of the IOR are critical to success. An experienced and knowledgeable IOR is vital to bring visibility, compliance, and control to the customs clearance process.<\/p>\n

The complexity of the role of the importer of records for clinical studies varies from country to country, and restrictions can be inconsistent. For example, in some regions and countries, only the pharmaceutical company, contract research organization, or sponsor can act as the IOR. In other global regions, the IOR can be a third party.<\/p>\n

\"clinical<\/p>\n

<\/h2>\n

Communication Is Part of The Plan<\/b><\/span><\/h2>\n

A careful review and verification of documents allow a more streamlined process for customs clearance and reduces, even eliminates, the likelihood that customs will stop the shipment during the clearance process.<\/p>\n

\"clinical<\/p>\n

To eliminate your study team finding itself <\/span>running around in circles, it is vital to engage in early planning and communications with <\/span>your in-country <\/span>IOR. This greatly reduces the likelihood of customs chaos. As the owner of the items being shipped (<\/span>clinical study and site <\/span>print materials, ancillary trial supplies and equipment, electronic and medical devices, etc.), <\/span>it is your responsibility to:<\/p>\n